Business
Why the Noxopharm (ASX:NOX) share price is jumping 14% higher today
While the S&P/ASX 200 Index (ASX: XJO) is slipping today, the Australian clinical-stage drug developer Noxopharm Ltd (ASX: NOX) is bucking the trend with its shares rising.
At the time of writing, the Noxopharm share price is up 14.13% to 52 cents.
Why is the Noxopharm share price increasing?
Cancer drug update
Noxopharm released a shareholder update to the market this morning pertaining to its drugs in development.
In the update, Noxopharm states that its immunotherapy drug, Veyonda, is emerging as a major new treatment. The company goes on to describe the potential value as ‘multi-billion dollar’, based on its ability to boost the effectiveness of all 3 current methods of cancer treatment: immune-oncology therapy,…
-
General14 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General17 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News3 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General21 hours agoPrincess Diana enters Paris waxwork museum in ‘revenge dress’